VOLUNTEER FOR RESEARCH
Hemp-Derived Cannabidiol (CBD) for Anxiety
This project is an FDA-approved clinical trial of a hemp-derived, high-CBD sublingual product for the treatment of anxiety.
Participants are assessed at 7 visits over the course of 6 weeks.
The primary outcome measures of the study are clinical state measures related to anxiety. Additionally, participants will complete measures related to quality of life, sleep, and activity levels, and cognitive testing.
Visit https://clinicaltrials.gov/show/NCT04286594 for more info
Individuals with moderate to severe anxiety who are interested in using a hemp-derived high CBD product may be eligible.
We are currently recruiting individuals for the open-label phase (all participants would receive active treatment).